Agree, and to your point I have read and watched most of the latest interviews given by Holmes. In no place she claims that Theranos is using blood collected in

Agree, and to your point I have read and watched most of the latest interviews given by Holmes. In no place she claims that Theranos is using blood collected in nanotainers (non-venous blood or finger prick blood) for assay (component detection) using traditional diagnostic equipments. Theranos uses non-venous blood for their proprietary tests (currently only 1 test) and rest 99.9% (figuratively speaking) tests uses venous blood in traditional diagnostic equipment. Back to the same question - If almost all of their tests are done using traditional equipments, then why $9B valuation?